WealthCollab’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$907K Buy
756
+635
+525% +$649K 0.33% 38
2026
Q1
$111K Hold
121
0.05% 113
2025
Q4
$130K Hold
121
0.05% 110
2025
Q3
$92.3K Sell
121
-1
-0.8% -$744 0.04% 124
2025
Q2
$95.1K Hold
122
0.05% 109
2025
Q1
$101K Buy
122
+2
+2% +$1.66K 0.06% 97
2024
Q4
$92.6K Buy
120
+6
+5% +$4.97K 0.06% 98
2024
Q3
$101K Hold
114
0.07% 103
2024
Q2
$103K Buy
114
+10
+10% +$8K 0.07% 89
2024
Q1
$80.9K Hold
104
0.06% 104
2023
Q4
$60.6K Buy
+104
New +$60.7K 0.05% 129

Other funds holding LLY

WealthCollab's LLY Position: Q2 2026 in Review

WealthCollab increased its Eli Lilly (LLY) stake by 525% in Q2 2026, buying an estimated $649K and bringing the position to 756 shares worth $907K. The position accounts for 0.33% of the portfolio, ranked #38.

WealthCollab first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WealthCollab held 756 shares of Eli Lilly worth $907K as of Q2 2026.
  • WealthCollab bought 635 Eli Lilly shares in Q2 2026, an estimated $649K.
  • Eli Lilly made up 0.33% of WealthCollab's portfolio in Q2 2026, its #38 holding.
  • WealthCollab first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.